The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project

Related News Articles

Headline
The Center for Medicare and Medicaid Innovation yesterday released its 2024 Report to Congress that includes updates on 37 models and initiatives (including…
Chairperson's File
In this Leadership Dialogue, I talk with Amy Perry, president and CEO of Banner Health, based in Phoenix. Before joining Banner Health three years ago, Amy…
Perspective
Congress returns to Washington, D.C., next week following the summer recess, and lawmakers can expect a busy fall as they face a full plate of issues that need…
Headline
AHA Immediate Past Chair John Haupert, president and CEO of Grady Health System in Atlanta, opened the afternoon plenary session during the second day of the…
Headline
AHA President and CEO Rick Pollack opened the 2024 AHA Leadership Summit in San Diego discussing the similarities of the U.S. Navy Seals to the hospital field…
Perspective
While Congress passed legislation last month to fund the federal government through September, it’s looking like there will be very few other pieces of…